Fig. 2From: An integrated approach of bioinformatic prediction and in vitro analysis identified that miR-34a targets MET and AXL in triple-negative breast cancerExpression of miR-34a, AXL, and MET in MDA-MB-231 and SK-BR-3 cell lines before miR-34a inductionBack to article page